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The cellular response to the extracellular matrix (ECM) microenvironment mediated by integrin adhesion is of fundamental
importance, in both developmental and pathological processes. In particular, mechanotransduction is of growing importance in
groundbreaking cellular models such as induced pluripotent stem cells (iPSC), since this process may strongly inﬂuence cell fate
and, thus, augment the precision of diﬀerentiation into speciﬁc cell types, e.g., cardiomyocytes. The decryption of the cellular
machinery starting from ECM sensing to iPSC diﬀerentiation calls for new in vitro methods. Conveniently, engineered
biomaterials activating controlled integrin-mediated responses through chemical, physical, and geometrical designs are key to
resolving this issue and could foster clinical translation of optimized iPSC-based technology. This review introduces the main
integrin-dependent mechanisms and signalling pathways involved in mechanotransduction. Special consideration is given to the
integrin-iPSC linkage signalling chain in the cardiovascular ﬁeld, focusing on biomaterial-based in vitro models to evaluate the
relevance of this process in iPSC diﬀerentiation into cardiomyocytes.
1. Introduction
The integrin protein family is a large group of transmem-
brane receptors, particularly involved in cell-extracellular
matrix (ECM) proteins and cell-cell adhesion. Moreover,
integrins constitute an important and functional bridge
between the ECM and the cytoskeleton and are able to
activate several intracellular signalling pathways. After the
ﬁrst report of their identiﬁcation [1, 2], in the last 30 years,
how the integrin protein family assumed a key role in
mechanotransduction biology, particularly as mediators of
a bidirectional signalling mode, has been extensively
reported. Integrins are able to read and transmit signals from
the extracellular microenvironment to the internal cellular
milieu, including the cytoplasm and nucleus (outside-in),
leading to a cellular reaction that may alter cell behaviour
and/or also the composition of the ECM (inside-out). Several
downstream mechanisms of integrins activate biochemical
signalling cascades which have impact on diﬀerent cell
functions by regulating crucial molecular pathways involved
in cell survival, proliferation, motility, and diﬀerentiation,
both in physiological and pathological scenarios [3–6].
In 2007, the groundbreaking discovery of a universal
protocol to reprogram mammalian somatic cells into induced
pluripotent stem cells (iPSC) [7], made by Takahashi and col-
leagues, brought immense potential to the ﬁelds of regenerative
and personalized medicine. In fact, these cells can diﬀerentiate
into cell types from all the three developmental germ layers:
ectoderm, mesoderm, and endoderm. iPSC-derived cells have
modelled, previously unreproducible, human diseases, e.g.,
long QT (LQT) syndrome [8], and have already been used in
two clinical trials for age-related macular degeneration [9]
and advanced heart failure [10].
The eﬃcacy of iPSC as a model system for the study of
the molecular mechanisms guiding pathological develop-
ment is tightly linked to the success of in vitro simulation
of the environmental cues responsible for cell fate in vivo.
Mechanosensing-mediated pathways are relevant not only
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for enhancing iPSC reprogramming eﬃciency [11] but also
for supporting iPSC-derived cardiomyocyte (iPSC-d-CM)
maturation [12]. Thus, several techniques have been proposed
for the design of substrates regulating integrin activation by
tuning chemical, geometrical, or mechanical parameters.
The last part of this review is dedicated to the discussion of
thesemethods and their relevance to spearheading the clinical
translation of the iPSC technology.
2. Integrin Structure, Extracellular Ligands, and
Focal Adhesion (FA) Complexes
The integrin family was ﬁrstly identiﬁed by using antibodies
against integrin β subunits which unveiled several coimmu-
noprecipitating proteins. Integrin heterodimers are com-
posed of noncovalently associated α and β subunits [3].
The heterodimeric structure and functionality of these recep-
tors were made clear only after the use of speciﬁc peptides,
e.g., arginine-glycine-aspartic acid (Arg-Gly-Asp; RGD tri-
peptide) and integrin α subunit-recognizing antibodies. To
date, it is well known that the integrin family is constituted
by 18 α subunits and 8 β subunits, possibly assembled in 24
diﬀerent heterodimers [13]. Depending on integrin subunit
composition, these molecules show speciﬁc extracellular
ligand properties and can be classiﬁed into 4 main subgroups
[14] listed in Table 1. This feature implies that the expression
pattern of integrins is tissue speciﬁc [3]. In addition to a large
extracellular domain, each heterodimer also has a transmem-
brane domain and a short cytoplasmic domain, which forms
a fundamental functional link with the cytoskeleton [14].
As shown in Table 1, cells expressing β1 integrin are gen-
erally outbound to collagen when associated with α1, α2, α10,
and α11 subunits. Otherwise, when β1 integrin is bound to
laminin, it is complexed with α3, α6, and α7 subunits.
Depending on which speciﬁc α subunit it heterodimerizes
with, β1 integrin recognizes the RGD motif (ανβ1, α5β1,
or α8β1) or leukocyte-speciﬁc receptors (α9β1, α4β1).
All integrin heterodimers containing αν subunits are speciﬁ-
cally associated with substrates with the RGD sequence. Sim-
ilarly, all integrins expressing β2 subunit are members of the
leukocyte-speciﬁc receptor-binding integrin subgroup. Lastly,
α6β4 integrin belongs to the previously mentioned laminin
receptor binding group [15].
It has been reported that β1 subunit-containing integ-
rins, such as α5β1, are predominantly recruited to the lead-
ing edge of cells moving on a 2D surface [16], whereas β3
subunit-containing integrins are responsible for the increase
in the number of focal adhesions (FA) and cell spreading
area because of its role in structural reinforcement of
adhesion [17, 18].
Since integrins work as receptors of several ECM compo-
nents, they strongly contribute individually to FA-mediated
signalling and rigidity sensing by mechanically changing
their structural conformation. In external force mechanosen-
sing, this integrin function can be considered as a primary
step, followed by a series of secondary mechanosensor
activities, which respond intracellularly to force-dependent
alterations. Thus, extracellular tension transmitted through
integrins elicits the binding of several intracellular elements,
which in turn activate themselves and strengthen the integrin
connection to actin (Figure 1(a)). Among these intracellular
factors, the main ones involved in mechanotransduction
are talin, vinculin, kindlin, α-actinin, zyxin, ﬁlamin, and
p130Cas. The interaction of integrin cytoplasmic tails with
one of these adaptor proteins, such as talin, is the main
mechanism leading to full integrin activation. For example,
talin, together with vinculin, plays a crucial role in the
force-dependent stabilization of FA by changing its con-
formation after tension. Talin binds through its FERM
(four-point-one protein/ezrin/radixin/moesin) domain to
the NPxY amino acid motifs on integrin tails, inducing their
activation [19–21]. Vinculin presents a self-inhibited state,
exerted by its head and tail domain interaction [22], and
becomes activated after its tail domain binds to α-actinin
alone or together with actin and phosphatidyl-inositol-4,5-
bisphosphate (PIP2) [23–26]. An increase in cellular tension,
which is strictly related to ECM stiﬀness and cytoskeletal
recruitment, stabilizes vinculin in the activated conforma-
tion, and leads to its FA recruitment [27, 28]. Another coop-
erating adaptor protein is kindlin which contributes to
integrin activation [29, 30]. Until this link of the mechano-
transduction chain, talin and vinculin act as direct mechani-
cal sensors, able to feel ECM properties, while α-actinin, a
spectrin superfamily component important for the structural
organization of the cell, also provides a scaﬀold to connect
the mechanotransduction chain with the previously men-
tioned downstream eﬀectors [31]. Thus, α-actinin is an indi-
rect link in the mechanotransduction chain. For this reason,
cell stretching could result in the dissociation of several pro-
teins that are weakly bound to α-actinin at multiple sites [32].
Among these weakly bound proteins, zyxin binds a central
region of α-actinin [33]; when a certain type of mechanical
stimulus occurs, this molecule translocates from FA to stress
ﬁbres [34]. Other connecting proteins between integrins and
actin such as ﬁlamins [35] play a mechanoprotective role
by stabilizing the actin cytoskeleton through linkage to
the cytoplasmatic membrane. In fact, under mechanical
stress, ﬁlamin domains change their conformational status
considerably [36]. This event leads to extension and revers-
ible unfolding [37], which allows ﬁlamin stretching and sub-
sequent protection of the linkage between F-actin and the
cytoplasmatic membrane [38]. Interestingly, force applied
through clustered β1 integrins leads to the transcriptional
upregulation of ﬁlamin A [39].
Lastly, Src family kinase p130Cas (Cas: Crk-associated
substrate) contains a N-terminal SH3 domain, which binds
the polyproline motifs of the tyrosine kinases, FA kinase
(FAK) [40, 41], and other proteins such as vinculin [42].
The SH3 domain is followed by a large substrate domain with
15 repetitions of the YxxP motif (where x is any amino acid),
which is a main site of tyrosine phosphorylation on the Cas
molecule [43]. Once phosphorylated, the p130Cas SH3
domain serves as a docking site for the SH2 domains of Crk
or Nck adaptor proteins [44, 45]. In nonadherent cells,
p130Cas is localized in the cytoplasm and, after integrin
receptor activation, translocates to FA where the phos-
phorylation of substrate domain tyrosine residues takes
place [46]. p130Cas activation after integrin engagement
2 Stem Cells International
regulates the reorganization of the actin cytoskeleton and
cell processes, such as spreading and migration [47]. More-
over, this tyrosine phosphorylation triggers signalling path-
ways leading to the regulation of cell survival and
proliferation [48, 49]. Recently, investigators highlighted
how p130Cas is able to inﬂuence actin remodelling and con-
comitant muscle-speciﬁc gene expression [42, 50].
2.1. Mechanical Stress-Reactive Nuclear Complexes. Based on
the previous discussion, it can be said that cells perceive,
adapt themselves to, and modify the ECM microenviron-
ment physical features by using speciﬁc protein structures
including the mechanosensing machinery of cell-ECM
and cell-cell interactions, secondary mechanosensors, and
diﬀerent mechanotransduction pathways. Interestingly, this
mechanism is mediated by a direct eﬀect of mechanical
linkage which is speciﬁc and suﬃcient to transmit the
extracellular stimuli into the nuclei [42, 54, 55].
The strong and intimate relationship between integrins,
FA, actin cytoskeleton, and nuclear structures has been well
documented in the last years. Several lines of evidence report
that actin ﬁbres communicate the mechanical properties of
the internal cellular environment to the nucleus and conse-
quently strongly aﬀecting gene regulation and expression
[56, 57]. The nucleus contains a stratiﬁed network of media-
tors, linking the nuclear envelope to the nucleoskeleton and
chromatin (Figure 1(b)). Structural alterations of nuclei are
responsible for gene modulation of multiple mediators such
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Figure 1: Cytoplasmatic membrane and nuclear envelope mechanotransduction protein complexes. (a) The image depicts the main
mediators involved in the mechanotransduction chain, starting from the integrin subunits, speciﬁcally binding ECM compounds, to
cytoskeleton polymerization, through the activity of focal adhesion eﬀectors. (b) The ﬁgure summarizes the link between cytoskeleton and
nuclear lamin A/C, through the nuclear envelope complexes, responsible for the gene expression modulation downstream to
mechanotransduction.
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as those related to mechanotransduction and diﬀerentiation
[58]. The nuclear lamina consists in ﬁlamentous lamin pro-
teins (lamins A, B, and C) that form the mechanical support
of the inner nuclear membrane. Several other membrane
proteins, including LAP2, emerin, and MAN1, are essential
nuclear constituents [59]. To date, it is well known that the
cytoskeleton is strongly linked with the nuclear lamina [60];
nevertheless, most of the current information is derived
from studies on isolated nuclei [61]. Two distinct protein
families, the SYNE/nesprin family and the SUN family
[62] colocalize in the nuclear membrane and are connected
both with cytoskeleton and nuclear lamina. Studies on C.
elegans revealed that homologues of nesprin 2 and SUN1/2
were associated with actin, at their N- and C-terminals,
respectively. For this reason, the term LINC was coined,
indicating that these protein structures were linkers of
nucleoskeleton and cytoskeleton [63, 64]. Every molecular
component of this important complex shows distinct bind-
ing peculiarity; while nesprins 1 and 2 are specialized in
actin, microtubule, and kinesin binding, on the other hand,
nesprins 3 and 4 are able to bind intermediate ﬁlaments
and microtubules, respectively [65–67]. Concerning the
SUN protein family, the oligomerization as a trimer of
these molecules is strongly required for nesprin binding
[68]. These molecular events, which were experimentally
observed on isolated nuclei, suggested their eﬀectiveness
in whole cell systems, thus supporting their contribution
to mechanical cues. Thus, isolated nuclei react to the phys-
ical forces in a similar manner to complete cells, because of
the presence of LINC complex, by which nuclei display
adhesion ability acting as force-sensitive signalling hubs
for cytoplasmic proteins and tuning nuclear responses to
various mechanosensory inputs [61]. Finally, among LINC
complex members, emerin plays a strategic role on the
inner nuclear membrane, since it can be phosphorylated
by Src kinases after a tension stimulus applied on isolated
nuclei through nesprin 1 [61]. This event overlaps lamin
A/C accumulation, which leads to the strengthening of
the nuclear membrane. It is important to point out that
Emery-Dreifuss muscular dystrophy is predominantly due
to emerin gene mutations [69]; moreover, cells derived
from emerin knockout transgenic mice show mechano-
transduction impairments [62, 70].
2.2. Mechanosensing Signalling Pathways. The major chemi-
cal signals elicited by mechanical stress at the cell surface
are as follows: (i) calcium inﬂux through cation channels
activated by stretch stimuli, (ii) activation of nuclear factor
kappa-B (NF-κB), (iii) stimulation of mitogen-activated pro-
tein kinases (MAPKs), and (iv) changes in the activity of
small GTPases, e.g., Ras, Rac1, and RhoA [71–79].
Peculiar mechanisms have been unveiled, e.g., the adap-
tor protein p130Cas which is physically stretched in response
to applied force both in vivo and in vitro. This stimulus
exposes the previously masked phosphorylatable sites of
p130Cas [80], that are substrates for Src family kinases which
trigger further downstream responses [81].
Among the previously mentioned signalling pathways,
there are two cascades which are strongly involved in the
context of integrin-mediated mechanotransduction, namely,
Rac1 and RhoA. In fact, these two members of the small Rho
family GTPases regulate actin assembly and contraction
[82, 83]. While active Rac1 controls actin polymerization
at the leading edges of motile cells and is involved in
lamellipodia focal complex formation, active RhoA is neces-
sary for stress ﬁbre formation. Notably, the two main RhoA
downstream eﬀectors are the diaphanous-related formin
protein mDia1, a formin family member that serves as an
actin nucleating factor and so facilitates actin polymerization
and assembly [42, 84–86] and the protein kinases ROCK-1
and ROCK-2, which promote actin contraction mediated
by nonmuscle myosin-II [82, 83].
One important feature of Rac1 and RhoA is that each of
these two mediators negatively regulates the other, leading
to a discrimination of the activity in certain cell subareas
[82], as depicted in Figure 2. Indeed, while some cell regions
show higher Rac1 activity responsible for moving and pro-
trusion, other subareas of the same cell with higher RhoA
activity are more concentrated on adhesion and contraction.
Several studies addressed the strong relationship between the
integrin-dependent mechanical stress and the sustained
modulation in Rac1 and RhoA activity [87–91]. As previ-
ously mentioned, several information on diﬀerent features
of small GTPase response to integrin-derived mechanical
stimulation are, to date, still missing, e.g., the exact signalling
time course and the types of cells and stresses involved. How-
ever, it is well established that mechanical stimulation leads
to small GTPase activity driving the cell to undergo a strong
and complex actin cytoskeleton remodelling which also
inﬂuences the adhesion features [92].
The main molecular events leading to the activation of
these numerous pathways are considerably distinct and
depend on the signal being activated. Activation of tyrosine
kinases and protein tyrosine phosphorylation play crucial
roles in the assembly and turnover of FA, as well as in
mechanotransduction. FAK and members of the Src family
are key tyrosine kinases, controlling FA functions and com-
plex stability [93]. After integrin engagement, FAK is
recruited to adhesion areas to provide both scaﬀolding and
kinase activity. The autophosphorylation of FAK deﬁnes a
docking site for Src kinase, which subsequently phosphory-
lates FAK on multiple tyrosine residues. All these events are
helpful for full FAK activation [94]. Following this, the
FAK-Src complex recruits the p130Cas protein and several
other adaptor proteins, phosphorylating multiple residues
on their sequence. After FAK autophosphorylation and the
generation of docking substrates for the SH2 domains of
the adaptor protein Crk (also known as p38), this interaction
leads to the activation of downstream signalling cascades,
such as Rac1 GTPase, previously reported as the pathway
involved in actin polymerization and the formation of new
focal complexes at the leading edge of the cell [95, 96]. It
has been demonstrated that inhibitors of actomyosin con-
tractility lead to a loss of tension due to a rapid dismantling
of FA [23, 27]. Mechanical tension activates guanine nucleo-
tide exchange factors (GEFs) for Rho, such as Vav2, GEF-H1,
or LARG, which subsequently induce GTP loading of Rho.
This leads, in turn, to the activation of downstream eﬀectors
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ROCK and mDia. Furthermore, several integrins containing
β1 subunits (e.g., α5β1) activate the pathway mediated by
Rho-ROCK-myosin-II to induce forces mediated by actomy-
osin (Figure 2), whereas αν subunit-containing integrins,
e.g., ανβ3 and ανβ5, are more involved in external force
adaptation and regulate both the stress ﬁbre synthesis and
FA area expansion through the pathway mediated by
Rho-mDia [97]. ROCK-mediated activation of myosin light
chain, together with inhibition of myosin light chain phos-
phatase, rapidly increases myosin-II activity and actomyosin
contractility (Figure 2). Overall, ROCK activity leads to actin
stress ﬁbre stabilization.
3. Integrins and iPSC
Human embryonic stem cells (ESC) and iPSC, obtained by
somatic cell reprogramming, are promising pluripotent stem
cells, with the potential for recapitulating monogenic diseases
and producing cell-based therapies [98]. In order to maxi-
mize the full potential of these cells, it is mandatory to
enhance investigation and knowledge on the best culture
conditions able to maintain plasticity, self-renewal, and
external stimuli responsiveness as well as attenuate cell death
events. Despite the lack of knowledge, there is increasing evi-
dence regarding the contribution of integrins on pluripotent
cell-ECM interaction [98–101].
The intricate and incompletely understood nature of cell
fate and potency routes was succinctly represented in the
self-acknowledged oversimpliﬁed [102]Waddington diagram
[103]which is based on original artwork created by John Piper
[104]. We have reimagined this iconic diagram to better
summarize integrin engagement for cell-cell and cell-ECM
binding and how these interactions aﬀect cell fate (Figure 2).
Mechanisms governing the transition from a somatic cell to
an iPSC, which is initiated by the expression of exogenously
acquired transcription factors, are continuously evolving,
and much eﬀort is directed to optimize the stochastic process
of cell fate rewinding, in order to achieve a fully predictable
process [105]. Reprogramming involves three sequential
steps: initiation, stabilization, and maturation [106]. Indeed,
molecular mediators, e.g., microRNA, or biophysical cues,
e.g., nanotopography, can supplement or replace some of
the classical reprogramming factors commonly used to
enhance reprogramming eﬃciency [107–113].
In this context, the activation of the transforming growth
factor-β (TGF-β) pathway and the expression of E-cadherin
are of interest. While the former is a potent inhibitor of
mesenchymal-to-epithelial transition, which is essential for
a successful reprogramming [114], the latter is not only
important for the maintenance of pluripotency and proper
colony morphology but is also an absolute requirement for
iPSC generation as well as the primary gatekeeper to the dif-
ferentiation progression [115]. Moreover, iPSC kinome-wide
functional analysis during reprogramming found a critical
role in the cytoskeletal remodelling process. Speciﬁcally, the
key serine/threonine kinases, testicular protein kinase-1 and
LIM kinase-2, phosphorylate the actin-binding protein coﬁ-
lin to modulate the cell reprogramming process.
Attempts have been made to transfer from the traditional
2D culture of iPSC to 3D culture in large-scale bioreactors, a
step which would facilitate iPSC culture on industrially and
clinically relevant scales [116, 117]. Since iPSC normally exist
in tightly packed colonies, their dissociation into single
cells, which is needed to ensure uniform cell distribution
and diﬀusion of treatments, is a major stressor and ini-
tially caused high rates of cell death before the routine
use of ROCK inhibitors during passaging [118]. Indeed,
approaches that prevent actin-myosin contraction, such
as downregulation of myosin heavy or light chains and
ROCK inhibition [119], protect cells fromcell deathprocesses.
Moreover, it has been demonstrated that a direct inhibition
































Figure 2: Integrin expression in iPSC at diﬀerent stages of diﬀerentiation. The picture on (a), inspired by the Waddington diagram and John
Piper’s original artwork [103], represents iPSC undergoing cardiomyocyte diﬀerentiation. During these early stages, cells lose their potency,
acquiring, in parallel, cardiomyocyte features. This process is linked to a speciﬁc integrin expression, further exacerbated by the growing
substrates. As displayed in (b), cells with a higher potency and a lower degree of diﬀerentiation express, on compliant substrates, a higher
amount of integrin heterodimers, preferentially containing αν integrin subunits. On the other hand, iPSC on rigid substrates lose potency
in favour of diﬀerentiation and express integrins with β1 integrin subunits.
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leads to a uniform diﬀerentiation of pluripotent stem cell
colonies [115].
To date, the generation of iPSC in two parallel states of
pluripotency has been described: naïve and primed [120].
Naïve iPSC are considered closer to a ground state, similar
to preimplantation epiblasts, while primed iPSC correspond
to cells found in the postimplantation epiblasts which are
ready or “primed” to diﬀerentiate [121–123]. The impor-
tance of the pluripotency state is crucial to understand and
to harness in research ﬁeld, as it is currently appreciated that
naïve and primed states have diﬀering biological functions,
e.g., developmental potency and chimeric contribution abil-
ity [124]. However, most of human iPSC are cultured in a
primed state; therefore, much attention focuses on deﬁning
the factors (frequently soluble factors) that can revert primed
cells to a naïve state [125–129]. A major driver to appreciate
the role of culture substrates in pluripotency continuum
came from the clearly recognizable morphological diﬀer-
ences in naïve and primed colonies: naïve cells form
dome-shaped 3D colonies, while colonies consisting of
primed cells possess a ﬂattened appearance. Despite the
lack of information on the eﬀect of growth substrates on
the pluripotency status, suppression of ECM-integrin sig-
nalling has been linked to the maintenance of naïve
human iPSC [130, 131].
Much of the information concerning ESC- and
iPSC-integrin interaction stems from the gradual transition
of feeder layer-cultured cell lines to more deﬁned matrices
such as Matrigel®, Cultrex BME®, Geltrex®, ﬁbronectin, col-
lagen IV, laminins, and vitronectin. A comparison of ESC
and iPSC mRNA microarray data revealed that the expres-
sion proﬁles of integrins are similar in both types of pluripo-
tent stem cells. Speciﬁcally, α5, α6, αν, β1, and β5 are all
abundantly expressed on iPSC; however, not all iPSC lines
displayed identical integrin proﬁles [132, 133]. Similarly,
the integrin α3, α5, α6, α9, αν, and β1 subunits, but not the
α1, α2, α4, α7, and α8 subunits, were identiﬁed as markers
of undiﬀerentiated porcine-primed ESC, with a subsequent
signiﬁcant increase in their adhesion features on ﬁbronectin,
tenascin C, and vitronectin coatings. The blockade of integrin
heterodimers α5β1, α9β1, and ανβ1 lead to a strong inhibi-
tion in cell-ECM adhesion [134]. Moreover, ανβ3, α6β1,
and α2β1 play a signiﬁcant role in the initial adhesion of
the human ESC to Matrigel [135]. Interestingly, human but
not porcine ESC display the active integrin heterodimer
α6β1 [136] suggesting species-dependent diﬀerences in the
mechanotransduction signalling context. Concerning iPSC
features, the parental cell-type origin impacts integrin expres-
sion, with enhanced levels of certain integrins observed in
iPSC derived from adherent cell types, e.g., foreskin ﬁbro-
blasts. Interestingly, Rowland and colleagues uncovered
important diﬀerences between human ESC and iPSC in terms
of the essential integrins necessary for initial adhesion and
subsequent proliferation on diﬀerent matrices. Speciﬁcally,
they showed thatβ1 is necessary for both functionswhen each
cell type was grown on Matrigel® whereas ανβ5 and β1 are
important for iPSC attachment and proliferation when cul-
tured on vitronectin as described in Section 2. Lastly, integrins
and integrin-mediated signalling are important in
maintaining iPSC self-renewal and pluripotency as indicated
by reduced Nanog, Oct-4, and Sox2 levels in α6-silenced iPSC
lines, localization of the FAK N-terminal domain in nuclei,
and AKT signalling activation [136, 137]. Similarly, murine
ESC interaction with the RGD peptide plays a role in the
expression of core transcription factors, i.e., Oct-4, Sox2,
and Nanog. Cyclic RGD synthetic compound supplementa-
tion was suﬃcient to mimic the eﬀect of a mechanical stimu-
lus, in terms of pluripotent gene expression. Speciﬁcally, this
molecule or mechanical stimulus signiﬁcantly inﬂuenced
ESC pluripotency by downregulating core transcription
factors. Moreover, RGD peptide, by inhibiting integrin
binding and, in turn, integrin expression [6], upregulated
early lineage markers (mesoderm and ectoderm) by leukae-
mia inhibitory factor (LIF) signalling [138]. Interestingly,
human ESC, expressing integrin α6β1, preferentially bind
human recombinant laminin-111, laminin-332, and lami-
nin-511, which are good substrates able to maintain undiﬀer-
entiated pluripotent human ESC cultures [139].
The ultimate destination of iPSC is diﬀerentiation along
speciﬁc cell lineages culminating in the generation of func-
tional terminally diﬀerentiated cells. Tailored protocols now
exist to generate most cell types from each of the three germ
layers, e.g., neurons, pancreatic islet β-cells, and, of speciﬁc
relevance to this review, cardiomyocytes. Subsequently, these
iPSC-derived cells can be used to model various diseases and
screen novel drugs. Early cardiomyocyte diﬀerentiation
protocols relied on the appearance of beating clusters within
stochastically formed embryoid bodies (EB). The ineﬃcient
nature of producing cardiomyocytes from EB leads to the dis-
covery of more eﬃcient methods for cardiogenesis. One
option considered here is the employment of small molecules
modulating the key stages of embryonic cardiac develop-
ment, i.e., early mesoderm formation by molecules targeting
bone morphogenetic proteins, the wingless/INT (Wnt) pro-
teins, and ﬁbroblast growth factors, followed by activation
of the conserved cardiac transcriptional program, i.e.,
Nkx2.5, Tbx5, Isl1, GATA4, and SRP. This program ulti-
mately leads to the expression of the structural proteins
essential for the function of cardiomyocytes, e.g., actin, myo-
sin light/heavy chains, desmin, and the troponins (elegantly
reviewed in [140]). Zeng et al. demonstrated that EB growth
and cardiac diﬀerentiation of EB rely on collagen/integrin β1
interaction [141]. Speciﬁcally, they observed a synergistic
upregulation of collagen and integrin β1 which peaked on
the third post diﬀerentiation induction day [141]. Interest-
ingly, the size and shape of EB as well as the conﬂuence of
iPSC are strongly linked to cardiogenic capacity [142–146].
The Wnt pathway is a pivotal pathway strongly linked to
iPSC self-renewal and diﬀerentiation which is exploited
by cardiomyocyte diﬀerentiation protocols relying on its
temporal activation and inhibition in order to achieve highly
eﬃcient cardiomyogenesis [145, 147]. The noncanonical
Wnt-planar cell polarity (PCP) pathway is able to induce
actin cytoskeleton change promotion through Rac1, RhoA,
and small GTPase signalling, which controls cell movement
and tissue geometrical features. Good examples are the
RhoA signalling cascade activated by DAAM1 and DAAM2
formin homology proteins or the JNK signalling cascade,
7Stem Cells International
which is activated by MAPKKK andMAPKK 4/7 [148, 149].
Critically, following prolonged Wnt/β-catenin activation,
the E-cadherin suppressors, SLUG and SNAIL, act as
watershed factors that turn the iPSC fate from self-renewal
to committed diﬀerentiation [150]. Lastly and more interest-
ingly, for the clinical relevance, is the observation of Zhao
and colleagues [151] who showed that the ROCK inhibitor,
Y-27632, enhanced the transplantation success (in terms of
engraftment) of human iPSC in a murine myocardial infarc-
tion model. The same compound revealed positive eﬀects
also on human ESC, e.g., increasing migration and support-
ing diﬀerentiation into EB. In the same study, integrin β1
blockade abolished the adhesion of ESC which decreased
their survival and pluripotent status [152].
3.1. Mechanotransduction and Cell Diﬀerentiation. The genes
under the direct control of the signalling pathways described
in Section 3 are multiple. In this section, we will focus on the
genes and pathways involved in pluripotent stem cell diﬀer-
entiation into cardiomyocytes.
An interesting 2013 study highlighted how
integrin-mediated response to strain can be modulated by
cell geometry more than by the cell area. Indeed, given
the relevance of cell geometrical cues in mechanotransduc-
tion, in several cell types, eﬃcient RhoA activation leads to
megakaryocytic leukaemia-1 (MKL-1) protein translocation
into the nucleus, in a cell shape-independent manner [153].
MKL-1 is a member of the so-called myocardin-related tran-
scription factor family and physically interacts with the serum
response factor (SRF) which activates SRF-dependent down-
stream gene transcription [154], e.g., actin cytoskeletal/-
FA-related proteins [155, 156].
In a previous study, it was shown that the skeletal α-actin
promoter activation, which is downstream of RhoA, was
strongly potentiated by β1 integrin expression and function.
These events were demonstrated to be speciﬁcally displayed
by cardiomyocytes, but not by NIH 3T3 ﬁbroblasts. This
observation further supported RhoA/SRF-dependent cardio-
myocyte gene expression by the β1 integrin signalling path-
way [157]. Concerning the role of SRF in stem cells, the
study of murine SRF−/− ESC showed that SRF deﬁciency
causes impairments in cell spreading, adhesion, and migra-
tion, due to cytoskeletal structure modiﬁcations in terms of
actin stress ﬁbres and FA. Moreover, stem cells lacking SRF
displayed downregulated FA, FAK, β1 integrin, talin, zyxin,
and vinculin [158]. Furthermore, depletion of the adhesion
molecule integrin β3, a key regulator of myogenic diﬀerenti-
ation and actin organization, attenuated p130Cas phosphor-
ylation and MKL nuclear localization during myoblast
in vitro diﬀerentiation [50].
The MKL-1/SRF pathway is ﬁrmly linked to another
important signalling pathway, strongly involved in mechano-
sensing in cardiovascular cells, namely, yes-associated protein
(YAP) and transcriptional coactivator with PDZ-binding
motif (TAZ) [159, 160]. Tuning YAP transcriptional activity
leads to the modiﬁcation of cell mechanics, force, and adhe-
sion and determines cell shape, migration, and diﬀerentiation
[161]. In the last years, this signalling pathway, deeply related
to the HIPPO pathway, which is strongly related to
developmental biology, is a hot topic inmechanotransduction
studies. Indeed, there are numerous papers describing the
involvement of YAP/TAZ in osteogenesis [159, 162].
Several studies underlined the indirect role of small
GTPase Rho in YAP/TAZ nuclear localization control,
exerted by promoting the actin bundles and stress ﬁbre for-
mation in response to cell spreading on the ECM [163–
165]. Nardone et al. in 2017 demonstrated that YAP nuclear
localization is controlled through Rho/ROCK activation and
YAP transcriptionally controls FA formation and cytoskele-
ton stability which, in turn, determines cell adhesion to the
ECM [161].
Experiments on conditional mouse YAP−/− and TAZ−/−
in the skin resemble the proﬁbrotic phenotype of
skin-speciﬁc loss of integrin β1, highlighting the strong
linkage and interplay of all these molecules in vivo [166].
Recently, β1 integrin-dependent cell adhesion was seen
as a critical element in mesenchymal cell proliferation, both
in vivo and in vitro. In fact, it was demonstrated that β1
integrin-dependent activation of the small GTPase Rac1
leads to YAP dephosphorylation and its nuclear shuttling,
conﬁrming that β1 integrin-dependent Rac1 function plays a
key role in YAP regulation, triggered by cell adhesion [167].
Another recent paper identiﬁed a pathway involving both
activation of integrin α3 and a FAK cascade-controlling YAP
phosphorylation and thus its nuclear localization in
transit-amplifying stem cells. In this work, the authors
highlighted that this speciﬁc signalling pathway potentiates
mTOR signalling, driving cell proliferation, and that the
YAP/TAZ signallingmechanism coordinates stem cell expan-
sion and diﬀerentiation during organ self-renewal [51].
4. Integrin Relevance in iPSC-Derived Cells: In
Vitro Biomimetic Approaches
As discussed in the ﬁrst section, mechanosensing, in general
and speciﬁcally integrin activation, can be used to guide
lineage-speciﬁc cell fate by activating mechanotransduction
pathways. In order to better elucidate the fundamental
mechanisms driving pathophysiological mechanisms, several
in vitro models, based on biomimetic approaches, have been
proposed and discussed. This section provides an overview of
the in vitro models (Figure 3), focusing on the potential of
biomimetic approaches to direct iPSC cardiomyocyte dif-
ferentiation and maturation, possibly supporting their use
in the ﬁeld of cardiovascular regenerative medicine and
tissue engineering.
4.1. Surface Chemistry. Substrate chemical composition and
the motifs decorating a given surface have a strong eﬀect
on selective integrin engagement. Here, we will discuss two
diﬀerent approaches to engineering substrates: the ﬁrst
employing ECM obtained by decellularization of biological
tissues and the second relying on the functionalization of
synthetic biomaterials.
4.1.1. Decellularized ECM. In vivoECM, thanks to its chemical
composition and mechanical/topographic properties, estab-
lishes the bases to support cell proliferation and diﬀerentiation
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[168, 169]. Indeed, the ECM surface does not only mediate cell
attachment by exhibiting anchorage sites for diﬀerent cell sur-
face receptors and coreceptors but also regulates the diﬀusion
of soluble factors secreted by the neighbouring cells, e.g.,
ECM composition modiﬁes chemical diﬀusion coeﬃcient
and, as a product of its own remodelling, releases functional
fragments constituting additional soluble factors.
For this reason, the use of decellularized tissues, main-
taining composition, architecture, mechanical properties,
and, interestingly, cell-binding domains, has been widely
proposed as a suitable scaﬀold for in vitro cell seeding, expan-
sion, and diﬀerentiation [170–174]. In parallel, its speciﬁc
capacity to guide stem cell diﬀerentiation has been also
shown [168, 175–177]. In particular, the ability to selectively
increase the expression of integrins [171] has been demon-
strated, underlining the relevance of ECM protein composi-
tion, e.g., the ratio of collagen, ﬁbronectin, laminin,
vitronectin [178], and their topology, supporting cell adhe-
sion and subsequently stimulating controlled cell diﬀerentia-
tion [171]. The potentiality of scaﬀolds realized by tissue
decellularization is maximized by the use of dynamic culture
methods, i.e., perfusion bioreactors supporting homogeneous
repopulation of the whole scaﬀold volume [179–181] and
recreating a controlled and reproducible 3D environment.
Nevertheless, although experiments are performed under
highly controlled culture conditions, the coexistence of
multiple parameters limits the understanding of the impact
of speciﬁc factors. Therefore, decellularized ECM scaﬀolds
are good multifactorial model systems, comprehensive of the
complexities of the in vivo scenarios, and are suitable for trans-
lational studies. On the other hand, biomaterials have been
designed and functionalized ad hoc, by means of either coating
with ECM components or generating speciﬁc cell-binding
domains, in order to interpret diﬀerent mechanisms.
The intermediate link in this chain is constituted by
3D bioprinting technologies. The technological advances
in the ﬁeld have allowed the use of liqueﬁed decellularized
tissues for high-resolution precise simulation of native tis-
sue structures, with encapsulated cells [182, 183], thus
providing the chance to observe the biological eﬀects
induced by ﬁne tuning of local chemical/architectural
matrix modiﬁcations.
4.1.2. Engineered Biomaterials. Polymers, both synthetic
and natural, have been widely used for the manufacture
of substrates and scaﬀolds intended for in vitro cell culture
and cardiovascular tissue engineering [184]. The most
used synthetic polymers in the ﬁeld are poly(ethylene-glycol)
(PEG), poly(lactic-acid) (PLA), poly(glycolic-acid) (PGA),
poly(ε-caprolactone) (PCL), and their copolymers such as
poly(lactide-co-glycolide) (PLGA) and polyurethanes (PU)
[185–190]. In contrast, natural materials include ECM con-
stituents, i.e., collagen, ﬁbrin, and silk [178, 191, 192].
The advantages of using engineered biomaterials rely on
their amenability to ﬁne-tune parameters, such as bio-
































Figure 3: Engineered materials supporting in vitro modelling. Integrin-mediated pathways relevant for iPSC cardiac diﬀerentiation can be
enhanced in vitro by the use of ad hoc-designed biomaterials. Toward this aim, chemical, geometrical, mechanical, and physical properties
of the substrates are relevant.
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functionalization with ECM proteins, integrin-binding pep-
tides, or growth factors [186, 193].
By coating synthetic materials, e.g., PU, with ﬁbronectin
(REDV, PHSRN, RGD, and GRGDSP), laminin (IKLLI,
IKVAV, LRE, PDSGR, RGD, and YIGSR), and collagen
(DGEA) sequences [194–196] together with supplementing
cell culture media with selective integrin inhibitors [197],
the eﬀect of integrin expression on cell attachment and pro-
liferation has been highlighted. In addition, polymer functio-
nalization with ECM peptides has been proposed to actively
promote cell diﬀerentiation. An example, performed with
an elegant and innovative approach, has been proposed by
Ovadia and colleagues [198]. Matrigel®, a commercial solubi-
lized basement membrane preparation extracted from the
Engelbreth-Holm-Swarm mouse sarcoma cells, consisting
of laminin, collagen IV, proteoglycans, and a number of
growth factors, is widely recommended as an iPSC culture
support. However, the speciﬁc reasons behind its success
have not been elucidated. In their work,Ovadia et al. proposed
iPSC single-cell encapsulation within 3D photopolymerized
with UV light (365 nm for 2 minutes) PEG-peptide-based
synthetic gels conveniently functionalized by a range ofmotifs
inspired by Matrigel and known to bind a variety of integrins
(including α6, αν, and β1), which generally promotes cell
adhesion. Knowing that ROCK inhibition increases the
expression of αν, α6, and β1 integrins during iPSC culture
on Matrigel®, in the proposed 3D culture system, the authors
showed that iPSC viability, growth, and diﬀerentiation were
enhanced in response to the environment, in particular to
β1 integrin activation.
Another parameter that needs to be taken into account
whenmodelling cell adhesion in vitro is the coupling strength
between integrin ligand and substrate. Human mesenchymal
stem cells exhibit enhanced osteogenesis in response to
high-strength binding which results from the activation of a
YAP-mediated pathway [199]. This result suggests that tradi-
tional covalent biological coatings could generate a bias in
data interpretation, which implies the need for novel coating
methods, such as noncovalent coatings [200]. Based on these
ﬁndings, it is clear that the study of integrin recruitment can
not omit the consideration of forces acting on thewhole chain,
from the substrate, e.g., substrate rigidity to the engaged
cytoskeleton ﬁlaments. Combinatorial approaches have been
implemented for the production of copolymers able to tune
cell-substrate interaction. An example of this approach is
provided by Cheng et al. [201], who demonstrated that novel
supramolecular PCL-containing self-complementary sextu-
ple hydrogen-bonded uracil-diamidopyridine moieties can
positively support cell attachment and proliferation. More-
over, as demonstrated by Chun et al. in 2015 [202], the
copolymer generated by polymerization of monomeric
ε-caprolactone with methoxy-PEG, in the ratio of 4%
PEG-96% PCL, was able to enhance iPSC-d-CM contractil-
ity, upregulating the expression of mature cardiomyocyte
markers such as myosin light chain-2ν and cardiac troponin
I. The authors demonstrated that these eﬀects are linked to
the engagement of a subset of integrins which activate a
mechanosensory transduction pathway regulated by the
polymerization of intermediate ﬁlaments.
4.2. Surface Topography. In vivo cardiac tissue functionality is
aided by the anisotropic tissue structure which results from
ECM protein organization, cell orientation, and cell-ECM/-
cell-cell junctions. In vitro, the relevance of ECM architecture
in iPSC maturation has been demonstrated by means of
micro- and nanostructured substrates. Results demonstrated
how geometrical cues could support iPSC pluripotency and
diﬀerentiation [203, 204] by the formation of cell-cell junc-
tions, not only leading to the generation of more functional
grafts, increased beating rate, and enhancing tissue-speciﬁc
protein arrangement, e.g., sarcomeric-actinin, connexin 43,
and troponins, but also allowing better stratiﬁcation of the
pathology, e.g., muscular dystrophy [203, 205–207].
At the aim of understanding the involvement of integrins
in geometrical feature-driven cell diﬀerentiation, substrates
controlling either cell shape and size or cell alignment or
spacing of adhesion ligands have been designed.
4.2.1. Cell Alignment. In vivo, physiological cardiac function-
ality is supported by coordinatedmuscular contraction, which
is allowed by highly organized cell alignment, guaranteeing
controlled anisotropic conduction of the electrical stimuli.
In vitro iPSC-d-CM assemble in heterogeneous randomly
organized clusters, missing accurate reproduction of the
in vivo scenario. This limits their level of maturation and
excludes from the in vitromodel the eﬀects of possibly relevant
mechanotransduction-guidedmechanisms. The introduction
of nanotopographical features into culture substrates, i.e.,
grooves in the 700–1000 nm range [11], has been demon-
strated to improve cardiomyocyte development by acting
on one hand through a reorganization of the integrin activa-
tion of the single iPSC (i.e., enhancing integrin expression
and formation of FA and increasing F-actin polymerization)
and, on the other, geometrically organizing the colony polar-
ization. Culturing on grooved substrates ﬁnally impacts on
iPSC-d-CM intrinsic molecular machinery, i.e., through the
activation of the YAP-dependent pathway [208, 209],
resulting in more physiological behaviours, showing a
reduction of arrhythmias and inducing more mature Ca2+
spark patterns [210, 211]. The maturity level not only
would beneﬁt from cell alignment but could permit a more
signiﬁcant stratiﬁcation of the pathology, as demonstrated
by the limited capacity of iPSC-d-CM from patients
aﬀected by Duchenne muscular dystrophy versus healthy
donors in their ability to reorient when cultured on grooved
substrates [212].
More recently, the introduction of polymeric nanowires
oﬀers the chance to couple cell alignment with electrical con-
ductivity and stimulation, reproducing preferential routes for
geometrical organization and electrical signal timing. The
application of this technology resulted in a signiﬁcantly more
advanced cellular structure, i.e., showed by cell-cell junction
formation, and contractile function eﬃciency [213–215],
enhancing in vitro iPSC-d-CM maturation and functionality
and leading towards the design of a better model system for
the evaluation of the in vivo pathophysiological mechanisms.
4.2.2. Cell Shape and Size. In between, the geometrical fea-
tures able to guide in vitro stem cell diﬀerentiation, shape,
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and size have been widely studied [216]. Indeed, several
screening platforms, also commercial platforms, e.g., BioSur-
face Structure Array, Nano-TopoChip [217], have been used
to demonstrate that by regulating the width/length ratio, in
the presence or absence of soluble factors, cell fate can be
moved from osteogenic to adipogenic commitment.
Regarding iPSC, they are often cultured as aggregates and
not as single cells; therefore, the mechanotransduction-driven
eﬀects of whole-colony size and shape should be taken into
account. Indeed, by controlling colony size, density, shape,
and spacing, Myers et al. [218] improved homogeneity in the
expression of pluripotency markers (SSEA4 and Nanog).
Moreover, the proposed micropatterning technique, through
the standardization of cell density, increased the percentage
of spontaneous beating cells. In particular, the generation of
circular patterns leads to the formation of connecting rings
of cardiomyocytes, supporting in vitro physiological electri-
cal behaviour, i.e., supporting the propagation of contractile
waves throughout the ring. Another example of how cell
shape, coupled with the supracellular structure, can be used
to promote in vitro cardiomyocyte maturation is provided
by the work of Xu et al. [211]. Here, by imposing
single-cell elongation by culturing on silicon-patterned sub-
strates, FA can be regulated to support alignment and
cell-cell contacts leading to increased cardiac diﬀerentiation
eﬃciency. Moreover, in their recent work, Grespan and col-
leagues [203] cultured iPSC onto microstructured (square
micropillars) silicon substrates and observed that, while
not aﬀecting pluripotency, nuclear deformability is sensibly
regulated during germ layer speciﬁcation, happening during
iPSC diﬀerentiation.
These observations, taken together, ﬁnally call for the
design of more complex in vitro substrates, taking into
account mechanosensing mechanisms for better iPSC
diﬀerentiation.
4.2.3. Integrin Clustering Methods. The methods described in
the previous paragraphs are based either on functionalization
of substrates by random decoration with integrin-binding
domains or by induction of adhesion sites by geometrical
constraint and do not encompass the relevance of integrin
geometrical distribution. It has been made possible to involve
this aspect thanks to the development of novel nanotechnol-
ogies, which can be divided in three diﬀerent approaches
[219]: (i) blending of polymers with diﬀerent degrees of
ligand incorporation [220, 221], (ii) nanoprinting lithogra-
phy of nanoparticle arrays [222–224], and (iii) transfection
of proteins by chimera constructs [225]. Results demon-
strated that not only identity, abundance, and density of
adhesion sites but also their spatial conﬁnement, including
global and local density, regulate cell adhesion [226],
migration, proliferation, and diﬀerentiation acting on both
cell-substrate and cell-cell contact [224]. Furthermore, the
capacity of nanoscale spatially organized cell-adhesive ligands
to direct stem cell fate was also demonstrated [210, 227].
4.3. Surface Elasticity. Substrate stiﬀness has been shown to
be a very strong mechanotransduction stimulus, regulating
physiopathological cell behaviour and cell reprogramming
and subsequently guiding the development of mature cell
phenotypes [164, 228–233]. In particular, regarding the
in vitro application of iPSC technology in the cardiac ﬁeld,
matrix rigidity can guide iPSC-d-CM diﬀerentiation: the
use of a substrate with compliance similar to that of
native cardiac tissue [234–236] supports cardiac commit-
ment and enhances metabolic maturity, sarcomeric protein
subtype, cardiac troponin T expression, and force generation
[230, 235, 237, 238]. The molecular events transferring the
force from the substrate to the nuclei, through cytoskeleton
engagement, have been described by Zhou et al. [239], and
other reviews discussed this topic at length [240, 241]. Here,
we will underline some speciﬁc aspects about the involve-
ment of integrins in this phenomenon. Indeed, the selec-
tive switching from the activation of β3 to β1 integrins
in response to reduced substrate stiﬀness has been demon-
strated [197, 242, 243]. From a technological point of
view, it is interesting to underline the sensitivity of the
whole traction chain to integrin-substrate binding force.
Indeed, a modiﬁcation in the substrate-anchoring strength
of integrin-binding ligands, i.e., choosing covalent binding
to obtain stable substrate coating, could lead to a misinter-
pretation of in vitro cell behaviour [15, 199, 244, 245],
thus highlighting the importance of considering mechani-
cal stimuli, i.e., surface elasticity, with the feeling of cells,
recognizing the role of all the nanoscale players.
4.4.Mechanical Stimulation.Mechanical stimulationhas been
demonstrated to regulate FA assembly,modulating the down-
stream pathways aﬀecting cardiomyogenesis [246–249].
Based on this assumption, several methods have been
described for the application of controlled mechanical stimu-
lation (i.e., temporal, spatial, and amplitude), some of them
aiming to verify the positive impact of integrin-mediated
adhesion pathways on iPSC reprogramming [113] and diﬀer-
entiation [250, 251]. Although far from being exhaustively
described, the pathways seem to be regulated by the change
in FA density and local conformation [252], followed by
impacting cytoskeleton rearrangement [56], ﬁnally regulating
cardiomyocyte maturity, e.g., cell-cell contact, sarcomeric
structure, and electrical activity. As an example, the intercon-
nection between the mechanical stimulation, in particular
shear stress, and the modulation of cellular electrical activity
was demonstrated by Roy andMathew [253], who underlined
how the gene encoding the α-subunit of human ether-a-go-
go-related gene (hERG) potassium ion channel could bemod-
ulated by integrins via a mechanoelectric feedback pathway.
Not only that mechanical stimulation enhances cell electrical
behaviour but that a positive eﬀect on maturation of cardio-
myocytes in vitro has been demonstrated by coupling pacing
withmechanical stimulation [254]. Finally, the in vitro imple-
mentation of mechanical stimulation has been shown of
beneﬁt in the model for the pathology stratiﬁcation. Chun
and colleagues proposed [249] that the application of cyclic
or static strain modulated the gene expression of a cell-cell
connection-related protein (connexin-43) in iPSC-d-CM
which was more pronounced in iPSC-d-CM from patients
aﬀected by primary dilated cardiomyopathy.
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5. Conclusions
Each integrin type is coupled to a diﬀerent combination of
signalling cascades which drive speciﬁc cellular processes,
e.g., stem cell diﬀerentiation [255, 256]. Integrins are involved
not only in the recognition of substrate composition but also
in sensing ECM rigidity and adapting cell morphology, motil-
ity, and fate to the mechanical properties of the matrix,
through the activation of mechanotransduction pathways.
However, the high speciﬁcity in the link between
integrin-mediated cell response to tissue-speciﬁc microenvi-
ronment is far from being completely decrypted, both in gen-
eral [15] and more speciﬁcally in pluripotent stem cells [98].
A detailed understanding of the cellular machinery linking
mechanosensing to mechanotransduction would be beneﬁ-
cial for eﬀective in vitro modelling and the future clinical
translation of tissue-speciﬁc diﬀerentiated iPSC.
As discussed in this review, the implementation of in vitro
novel biomaterials, taking into account integrin-mediated
mechanotransduction signalling, coupled with controlled
systems, i.e., microﬂuidic bioreactors, could be relevant
to improving the study of iPSC-d-CM diﬀerentiation
and supporting maturation [12, 257], inspired by an
“organ/lab-on-chip” approach [227]. The design of such
models would beneﬁt (i) in vitro modelling of the molecular
basis of the pathologies, (ii) in vitro evaluation of possible
mechanisms and speciﬁc molecular targets for personalized
pharmacological approaches, and (iii) development of a
mature cell source available for future transplantation per-
spectives. Indeed, the high risk of teratoma formation
intrinsic to transplantation of iPSC-derived cells is well
acknowledged. Moreover, the maturity of the implanted
cells, especially thinking about cardiac applications of
iPSC-d-CM, should guarantee their survival and function-
ality shortly after the procedure.
In conclusion, these aspects would raise the level of
iPSC-d-CM quality and provide an eﬀective model system
for the study of diﬀerent cardiac pathologies. Moreover,
in an optimal scenario, the use of bioactive scaﬀolds in
controlled culture systems could permit the utilization of
read-out parameters that provide a culture quality feedback
signal.
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